D,l-cis-2,3-pyrrolidine Dicarboxylate Alters [3h]-l-glutamate Binding And Induces Convulsions In Mice

This study investigated whether D,L-cis-2,3-Pyrrolidine dicarboxylate (D,L-cis-2,3-PDC), a new glutamate analogue, alters glutamate binding to cerebral plasma membranes and whether N-methyl-D-aspartate (NMDA) receptors are involved in the convulsant effect of this compound. D,L-cis-2,3-PDC reduced sodium-independent [3H]-L-glutamate binding to lysed membrane preparations from adult rat cortex and had no effect on sodium-dependent glutamate binding. Intracerebroventricular administration of D,L-cis-2,3-PDC (7.5-25 nmol/5 μl) induced generalized tonic-clonic convulsions in mice in a dose-dependent manner. The coadministration of MK-801 (7 nmol/2.5 μl), with D,L-cis-2,3-PDC (16.5 nmol/2.5 μl), fully protected the animals against D,L-cis-2,3-PDC-induced convulsions, while the coadministration of DNQX (10 nmol/2.5 μl) increased the latency to convulsions but did not alter the percentage of animals that had convulsions. These results suggest that D,L-cis-2,3-PDC-induced effects are mediated predominantly by NMDA receptors. © 2003 Elsevier Inc. All rights reserved.762295299Bradford, M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254Bridges, R.J., Stanley, M.S., Anderson, M.W., Cotman, C.W., Chamberlin, A.R., Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diasteroisomer (1991) J. Med. Chem., 34, pp. 717-725Carpes, M.J.S., Miranda, P.C.M.L., Correia, C.R.D., Stereoselective synthesis of conformationally restricted analogues of aspartic and glutamic acids from endocyclic enecarbamates (1997) Tetrahedron Lett., 38, pp. 1869-1872Chamberlin, A.R., Bridges, R.J., Conformationally constrained amino acids as probes of glutamate receptors and transporters (1993) Drug design for neuroscience, pp. 231-259. , A.P. Kozikowski. New York: RavenChoi, D.W., The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death (1990) Annu. Rev. Neurosci., 13, pp. 171-182Choi, D.W., Glutamate receptors and the induction of excitotoxic neuronal death (1994) Prog. Brain Res., 100, pp. 47-51Clark, W.G., Vivonia, C.A., Baxter, C.F., Accurate freehand injection into a lateral brain ventricle of the conscious mouse (1988) J. Appl. Physiol., 25, pp. 319-321Collingridge, G.L., Bliss, T.V.P., Memories of NMDA receptors and LTP (1995) Trends Neurosci., 18, pp. 54-56Conn, P.J., Patel, J., (1994) The metabotropic glutamate receptors, pp. 1-277. , Toyota (NJ): HumanaCotman, C.W., Kahle, J.S., Miller, S.E., Ulas, J., Bridges, R.J., Excitatory amino acid neurotransmission (1995) Psychopharmacology: The fourth generation of progress, pp. 75-85. , F.E. Bloom, & D.J. Kupfer. New York: Raven PressDaw, N.W., Stein, P.S., Fox, K., The role of NMDA receptors in information processing (1993) Annu. Rev. Neurosci., 16, pp. 207-222Debonnel, G., Beauchesne, L., Montigny, C., Domoic acid, the alleged "mussel toxin," might produce its neurotoxic effect through kainate receptor activation: An electrophysiological study in rat dorsal hippocampus (1989) Can. J. Physiol. Pharm., 67, pp. 29-33Emanuelli, T., Antunes, V.F., Souza, D.O.G., Characterization of L-[3H]glutamate binding to fresh and frozen crude plasma membranes isolated from cerebral cortex of adult rats (1998) Biochem. Mol. Biol. Int., 44, pp. 1265-1272Hollman, M., Heinemann, S., Cloned glutamate receptors (1994) Annu. Rev. Neurosci., 17, pp. 31-108Humphrey, J.M., Bridges, R.J., Chamberlin, A.R., 2,3-pyrrolidine dicarboxylates as neurotransmitter conformer mimics: Enantioselective synthesis via chelation-controlled enolate alkylation (1994) J. Org. Chem., 59, pp. 2467-2472Ishida, M., Shinozaki, H., Acromelic acid is a much more potent excitant than kainic acid or domoic acid in the rat spinal cord (1988) Brain Res., 474, pp. 386-389Kanai, Y., Smith, C.P., Hediger, M.A., The elusive transporters with a high affinity for glutamate (1993) Trends Neurosci., 16, pp. 365-370Kudo, Y., Akita, M., Ishida, M., Shinozaki, H., A significant increase in intracellular Ca2+ concentrations induced by (2S,3R,4S)-2-(carboxycyclopropyl)glycine, a new potent NMDA agonist, in cultured rat hippocampal neurons (1991) Brain Res., 567, p. 342Lanthorn, T.H., Hood, W.F., Watson, G.B., Compton, R.P., Rader, R.K., Gaoni, Y., Cis-2,4-Methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist (1990) Eur. J. Pharmacol., 182, pp. 397-404Madsen, U., Bang-Andersen, B., Brehm, L., Christensen, I.T., Ebert, B., Kristoffersen, I.T.S., Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists (1996) J. Med. Chem., 39, pp. 1682-1691Meldrum, B.S., Excitotoxicity and selective neuronal loss in epilepsy (1993) Brain Pathol., 3, pp. 405-412Nakanishi, S., Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity (1994) Neuron, 13, pp. 1031-1037Nicolletti, F., Bruno, V., Capani, A., Casabona, G., Knöpfel, T., Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? (1996) Trends Neurosci., 19, pp. 267-271Ortwine, D.F., Malone, T.C., Bigge, C.F., Drummond, J.T., Humblet, C., Johnson, G., Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists (1992) J. Med. Chem., 35, pp. 1345-1370Racine, R.J., Modification of seizure activity by electrical stimulation: II. Motor seizure (1972) Electroenceph. Clin. Neurophysiol., 32, pp. 281-294Rao, R., Murthy, R.K., Characteristics of [3H] glutamate binding sites in rat cerebellum (1993) Biochem. Mol. Biol. Int., 30, pp. 861-866Rothman, S.M., Olney, J.W., Excitotoxicity and the NMDA receptor-still lethal after eight years (1995) Trends Neurosci., 18, pp. 57-58Schoepp, D.D., Smith, C.L., Lodge, D., Millar, J.D., Leander, J.D., Sacaan, A.I., D,L-(tetrazol-5-yl)glycine: A novel and highly potent NMDA receptor agonist (1991) Eur. J. Pharmacol., 203, pp. 237-243Schoepp, D.D., Lunn, W.H.W., Salhoff, C.R., McDonald, J.W., The NMDA receptor agonist D,L-(tetrazol-5-yl)glycine is a highly potent excitotoxin (1994) Eur. J. Pharmacol., 270, pp. 67-72Shinozaki, H., Ishida, M., Shimamoto, K., Ohfune, Y., A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-α-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord (1989) Brain Res., 480, pp. 355-359Szatkowski, M., Attwell, D., Triggering and execution of neuronal death in brain ischaemia: Two phases of glutamate release by different mechanisms (1994) Trends Neurosci., 17, pp. 359-365Watkins, J.C., Krogsgaard-Larsen, P., Honore, T., Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists (1990) Trends Pharmacol. Sci., 11, pp. 25-33Willis, C.L., Humphrey, J.M., Koch, H.P., Blakely, T., Ralston, L., Baker, C.A., L-Trans-2,3-pyrrolidine dicarboxylate: Characterization of a novel excitotoxin (1996) Neuropharmacology, 35, pp. 531-539Willis, C.L., Dauenhauer, D.L., Humphrey, J.M., Chamberlin, A.R., Buller, A.L., Monaghan, D.T., Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine- dicarboxylate: Enhanced excitotoxic potency and selectivity (1997) Toxicol. Appl. Pharmacol., 144, pp. 45-5